Non-Medicalized Medical Transport For The Ch De Villeneuve De Berg
Upgrade to view
France
01-10-2025
Tender Notice
Request For Participation: Procurement Of Transportation Services Supporting The Mobility Of The Elderly And Disabled Dps
Upgrade to view
Finland
16-12-2030
Tender Notice
Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Guselkumab (L04Ac16) Within The Framework Of A So-Called Open-House Model.
Upgrade to view
Germany
31-10-2026
Tender Notice
Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Cetrorelix (H01Cc02) Within The Framework Of A So-Called Open-House Model.
Upgrade to view
Germany
31-10-2026
Tender Notice
Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Fluorouracil, Combinations (D11Af55) Within The Framework Of A So-Called Open-House Model.
Upgrade to view
Germany
31-10-2026
Tender Notice
Procurement Of Social And Healthcare Passenger Transport And Other Transport Services As Needed
Upgrade to view
Finland
15-10-2032
Tender Notice
Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Vildagliptin (A10Bh02) Within The Framework Of A So-Called Open-House Model.
Upgrade to view
Germany
30-09-2026
Tender Notice
Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Ertugliflozin (A10Bk04) Within The Framework Of A So-Called Open-House Model.
Upgrade to view
Germany
30-09-2026
Tender Notice
Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredients Brinzolamide And Brimonidine (S01Ec24) Within The Framework Of A So-Called Open-House Model.
Upgrade to view
Germany
30-09-2026
Tender Notice
Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Filgotinib (L04Af04) Within The Framework Of A So-Called Open-House Model.
Upgrade to view
Germany
31-08-2026
Tender Notice